...
首页> 外文期刊>Bulletin of experimental biology and medicine >Neuroprotective and Antiamnestic Effects of a New Drug Emopag in Rats
【24h】

Neuroprotective and Antiamnestic Effects of a New Drug Emopag in Rats

机译:一种新药物Emopag在大鼠中的神经保护和抗动化作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Emopag, a new drug, preventively administered in doses of 10 and 30 mg/kg/day over 4 days produced a pronounced neuroprotective effect in the model of brain ischemia caused by gravitational overload and reduced animal mortality from 17 to 0%. The preparation more effectively corrected neurological deficit than the reference drugs Mexidol (in considerably larger doses of 30 and 90 mg/kg/day) and antihypoxic drug amtizol (30 mg/kg/day). Moreover, Emopag exhibited considerable antiamnestic activity comparable to that of Mexidol (in 3-fold higher doses); in a dose of 30 mg/kg/day Emopag was more effective than Mexidol and amtizol in the same dose. Thus, Emopag showed marked neuroprotective and antiamnestic effects in the model of gravitational overload in rats.
机译:Emopag是一种新的药物,以10和30mg / kg /天的剂量预防性给药,在4天内产生了在引力过载引起的脑缺血模型中的明显神经保护作用,从17〜0%降低了动物死亡率。 该制剂更有效地校正了神经功能缺陷,而不是参考药物茂物蛋黄(以相当大的剂量为30和90mg / kg /天)和抗氧氧化药物氨苄醇(30mg / kg /天)。 此外,EMOPAG表现出与Mexidol(以3倍的剂量为3倍)的相当大的抗突性活性; 在30mg / kg /天的剂量中,Emopag比Mexidol和Amtizol在同一剂量中更有效。 因此,Emopag在大鼠引力过载模型中显示出明显的神经保护和抗抗症效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号